- Kaiser Permanente names SVP, Fresno service area manager
- Nebraska hospital CEO resigns amid allegations of $38K in improper spending
- Northwell’s direct contracting business wants to ‘link up’ with other health systems
- PDS Health among 1st to deploy Epic-integrated AI platform
- CommonSpirit’s 5 targets for judging payer prior auth reform — and its Humana milestone
- LifeBridge names division president
- Private equity struggles in healthcare amid mounting pressures: 5 notes for dentistry
- Who’s actually winning the fight for ASC ownership?
- Why some ASCs are buying their own anesthesia groups
- Hospital Sisters Health System names chief technology officer
- Top Medicare Advantage plans for member satisfaction in 2026: JD Power
- How a 12-hospital system saved millions with an inventory overhaul
- Corporate medicine is burning out 90% of employed physicians: 10 survey findings
- HCA Florida hospital names assistant CFO
- GE HealthCare taps new CFO
- 6-property outpatient portfolio acquired
- Patients deserve every evidence-based option for mental healthcare
- 10 anesthesia controversies in 2026
- The $314K cost of employing a physician
- Who’s driving physician M&A in 2026? 5 deals to know
- 5 ways insurers are undercutting anesthesia payments: ASA
- Prior GLP-1 use doesn’t affect bariatric surgery results: 6 things to know
- Statement on Regulation Crypto Assets: Fit-for-purpose Exemptions for Crypto Market Innovation
- Filling the Regulatory Tank: Regulation Crypto Assets Proposing Release
- Statement on Regulation Crypto Assets
- Dental therapy program enrollment up 533% in 5 years
- Dental assisting program enrollment down 5.2% in 5 years
- Dental hygiene program enrollment up 15% in 5 years
- Surgery Partners ditches its $200M M&A target in favor of de novo growth: 5 things to know
- The dental specialties DSOs will prioritize next
- Statement on Commencement of Appointment Process for Public Company Accounting Oversight Board Seat
- Dental school enrollment in the 10 states with the most dental shortage areas
- How To Protect Yourself During Wildfire Season
- Ballmer Institute lands $125M to expand child behavioral health training nationwide
- Judge weighs whether man charged with killing dentist can act as own attorney
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
- Included Health to offer Carrum specialty care for alternative plan members
- 52 behavioral health executive moves to know
- Hospital performance improves in June, but lags 2025
- University of Toledo gets nearly $2M to support behavioral health workforce
- CTA reporting requirements eliminated for most dental practices: 5 things to know
- National Alliance on Mental Illness names chief medical officer
- Pennsylvania opens 24/7 behavioral health crisis center
- Cyber criminals target DSOs, dental groups: 3 updates
- OpenAI boosts mental health safeguards for teens
- UnitedHealthcare expands behavioral coaching to 13 million members
- Kindergarten Vaccine Exemptions Hit Record High, New CDC Data Shows
- Loneliness Is A Health Crisis, But Doctors Alone Can't Cure It, Analysis Argues
- Ousted OHSU Healthcare CEO files lawsuit alleging wrongful termination, discrimination
- JD Power: Member satisfaction with Medicare Advantage plans continues to slide
- AMA applauds updated CMS prior authorization reporting guidance
- Constipation In Space: A New Study Provides Answers
- Social Media Beauty Trends May Up Teens' Exposure To Hormone-Disrupting Chemicals
- HIPAA-compliant marketing platform Ours Privacy lands $15M amid growing pixel concerns
- Pharma commercialization partner Valeris brings in new strategy chief
- Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS’ global test
- CSL shares up 17% as immunoglobulin boost points to signs of recovery
- R1 acquiring Humata Health to bolster AI-powered prior authorizations
- Revance hires Janelle Wichmann as chief marketing officer of skincare unit
- CMI adopts orphan drug field with dedicated center of excellence
- Waist Size Is Accurate Way To Gauge Unhealthy Excess Weight, Study Says
- Panel Offers First Guidelines For Using E-Cigarettes To Help Smokers Quit
- Celcuity keeps cool amid questions about Revtorpyk launch timing
- Newsom Promotes Affordable Insulin, But California's Generic Label Off To A Slow Start
- What Geriatric Emergency Departments Do Differently
- Drive for Nuclear Power Boosts Uranium Industry — And Tribal Health Concerns in Southwest
- Rural primary care company Hopscotch clinches $53M to expand beyond NC
- Eurofins expands operations to meet growing high-potency API demand
- 24 new behavioral health projects to know
- Four health systems, including Ochsner and Denver Health, go live with Epic's real-time prior authorization checks
- 8 new psychiatric residency programs to know
- DocGo agrees to acquire virtual care provider Hicuity Health, assumes $52M debt
- Papa, eternalHealth expand partnership around Plus platform
- Happy Health secures $75M to expand AI-powered care in the home starting with sleep apnea
- As healthcare costs weigh on patients, states could play a bigger role, report finds
- Jalapeño Recalls Keep Growing As Salmonella Outbreak Investigation Continues
- Music Streaming Linked To Rise In Traffic Deaths
- EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu
- Quanovate takes back marketing claims for Mira fertility wand after P&G challenge
- Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition
- Whoop expands Advanced Labs to non-members, adds Grail’s multi-cancer detection test to lineup
- Quartz Countertop Workers Are Falling Prey To Lung Disease
- Kaiser Permanente notches 4.6% Q2 operating margin, $5.3B net income
- Epic faces Federal Trade Commission antitrust investigation, Reuters reports
- Innovaccer, Mastek ink strategic partnership to scale agentic AI in healthcare globally
- Sandoz strikes $322M biosimilars deal with Shanghai Henlius
- Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication
- Many Smokers Unaware Of Heart, Brain Risks Of Smoking
- Tylenol, Other Medications Fuel Spike In Liver Damage Cases, Poison Center Data Says
- AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
- My Husband Was Kicked Out Of Hospice For Dying Too Slowly
- Tadalafil (Cialis), Used for BPH and ED, Might Increase Glaucoma Risk, Study Says
- Kennedy’s Quiet Hunt for Autism Culprits Stalls as Trump Orders Baseless Changes to Childhood Shots
- Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start
- Inside agency view: Real Chemistry’s Frank Mazzola on audience nuance and rewarding creativity
- Abridge expands AI decision support to more clinicians in bid to become healthcare's copilot
- Danish politicians call out Eli Lilly obesity campaign
- Universal Health Services closes $835M Talkspace acquisition
- Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order
- States Enact Emergency Orders On Kratom While Awaiting Federal Rules
- Study examines how ICHRA adoption could help stabilize ACA risk pools
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Screen Time Is Not All Bad For Kids' Brains
- Processed Foods Linked To Prostate Cancer Risk
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Industry Voices—AI should help cancer patients survive the healthcare system
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- It's crunch time for Karyopharm as company faces potential default next month
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- How consumerization is reshaping pharma marketing
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- FDA Wants More Information From Food Makers On New Food Chemicals
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Beyond Compliance: Rethinking No Surprises Act strategy
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
Michigan healthcare freedom community forum
Department of Health and Human Services Secretary Kennedy reconstituted the Interagency Autism Coordinating Committee (I-ACC) in January with 21 new public members. Now beginning their mandate, they have attacted a great deal of criticism from the establishment:
Kennedy's new US autism panel to examine potential causes
By Leah Douglas and Ahmed Aboulenein - March 5, 2026Summary
- New panel includes vaccine skeptics, raising concerns among autism experts
- Panel could explore controversial vaccine links
- Outside experts warn focus on vaccines may divert funds from other autism research
WASHINGTON, March 5 (Reuters) - A U.S. autism advisory board remade by Health Secretary Robert F. Kennedy Jr. to include vaccine skeptics aims to steer federal research spending toward investigating causes of the condition, as well as other issues like co-occurring medical disorders, according to some new panel members.
Kennedy, a longtime anti-vaccine activist who has suggested the inoculations cause autism, contrary to scientific evidence, reset the Interagency Autism Coordinating Committee in January with 21 new public members. More than a third of the new committee members have also promoted the debunked link between vaccines and autism.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Some autism experts, including former committee members, have said the new members could undermine federal autism research. This week, some former members created their own alternative advisory board, the latest in a series of similar efforts by public health experts concerned about Kennedy's overhaul of federal vaccine policy and what they see as misinformation coming from agencies he oversees.No rigorous studies have found links between autism and vaccines or medications. Autism experts attribute rising rates of the condition largely to more inclusive diagnosis criteria.
The committee, due to first meet on March 19, will provide non-binding guidance to Kennedy on federal autism research priorities, including recommendations on allocating hundreds of millions of dollars in research spending.
Kennedy has promised President Donald Trump he will identify the cause of autism, which most researchers suggest is linked in part to genetics and exposure in utero to pollutants or harmful contaminants. Many of Kennedy's supporters in the Make America Healthy Again movement - some of whom were named to the committee - also believe vaccines can cause autism and advocate for fewer childhood vaccinations.
Committee chair Sylvia Fogel, a psychiatrist and instructor at Harvard Medical School, told Reuters the committee will address gaps in autism research like causal triggers in an effort to better serve people with profound autism and their families.
"Autism is not monolithic. Federal strategy should reflect that complexity rather than flatten it," Fogel said.
Department of Health and Human Services spokesman Andrew Nixon said the new committee is meant to unite a range of voices and that "expanding perspectives on the panel does not change the fact that federal research is grounded in rigorous science."
SOME MEMBERS LINK VACCINES AND AUTISM
Until January's overhaul, major autism groups like the Simons Foundation and Autism Speaks, and researchers from universities including Johns Hopkins and Tufts accounted for most of the committee's 21 members from the public.
That panel recommended further research into co-occurring physical and behavioral health conditions, like epilepsy, gastrointestinal issues and anxiety disorders, according to a draft 2024 report.
David Sitcovsky, vice president of advocacy at Autism Speaks, said in a statement that broader representation would strengthen the committee, but that its impact would depend on retaining a grounding in science.
The new panel contains more activists, just three autistic self-advocates - the minimum required by law - down from seven, and few representatives from research universities. At least eight have tied vaccination to autism or are connected to organizations that support those claims, including several who say their children developed autism after being vaccinated, according to a Reuters review of their public statements and affiliations.
Panel member Ginger Taylor, who created a website called "How Do Vaccines Cause Autism?", wrote in a Substack post that her top priority for the committee is investigating the link between vaccines and autism.
John Gilmore, a new panel member and co-founder of the Autism Action Network who says his 26-year-old son developed autism after being vaccinated, said he wants to steer more research toward rising autism rates.
"A lot of the voices that are on the (committee) now have been deliberately excluded for 20-odd years," he said.
Several, including Gilmore and Fogel, appeared on panels at a September autism event hosted by the MAHA Institute, whose president, Mark Gorton, is an anti-vaccine activist and was a significant funder of Kennedy's 2024 presidential campaign.
Asked how some members' views on vaccines will affect the committee's work, Fogel said studies of the measles-mumps-rubella vaccine and thimerosal-containing vaccines have not shown a causal link to autism.
"That body of available evidence is substantial and must be acknowledged," Fogel said.
Still, research should examine how various exposures, including immune or inflammatory stress, might affect autism outcomes, she said.
EXPERT CONCERNS
On Tuesday, a dozen autism advocates, researchers and several former committee members formed the Independent Autism Coordination Committee to create its own strategic plan for autism research.
Alison Singer, president of the Autism Science Foundation and a prior government committee member, said investing federal dollars into researching a link between vaccines and autism, which most experts consider settled science, would cut into funding for other research opportunities, like autism's heritability or link to environmental exposures.
"There’s not a bottomless pit of money at the NIH that can be used to fund research," Singer said. "If we devote our very limited resources towards reinvestigating vaccines, we won’t have money to look at actual potential causes of autism."
More on the self appointed Independent Autism Coordinating Committee (I-ACC), with a deceitful name and acronym deliberately chosen to confuse the public into thinking that it is the official Interagency Autism Coordinating Committee (I-ACC):
Autism researchers rebuke Kennedy, form independent advisory group
The group wants to be a bulwark against potential misinformation from federal health agencies
By O. Rose Broderick - March 3, 2026A group of autism researchers and advocates announced Tuesday the formation of an independent advisory body that will develop a scientific agenda for the autism community. They hope to act as a bulwark against a federal committee bearing a similar name and its new members who believe that childhood vaccines can cause autism, despite the lack of evidence for such a link.
The Independent Autism Coordinating Committee (I-ACC) will hold its first meeting on March 19 — the same day that the newly-reformed federal body, the Interagency Autism Coordinating Committee (IACC), will meet for its first publicly-announced meeting, as first reported by the Washington Post.
The independent body’s leaders see their group and future actions as a direct rebuke of health secretary Robert F. Kennedy Jr. and his decision to refashion the federal body with members who align with his views on autism and vaccines, instead of preeminent researchers and autistic self-advocates.
“We don’t believe that the new federal IACC is going to pursue the kinds of areas and priorities that the mainstream scientific community feels are important at this point,” said Helen Tager-Flusberg, a member of the new group and director of the Center for Autism Research Excellence at Boston University.
The independent group includes many former members of the federal body, such as Joshua Gordon, former National Institute of Mental Health director, and Alison Singer, president of the Autism Science Foundation. The 12 members are mostly researchers, a contrast with the federal body, whose members mostly focus on advocacy.
Tager-Flusberg says the group will not rehash every matter the federal body considers, but they will primarily determine which topics within autism research deserve the most attention, with an eye on informing the decisions of non-governmental funders. The group will continue to meet whenever the federal body meets in an attempt to halt any misinformation that emerges from the meeting. If, for example, IACC plans to discuss vaccines and autism, the researchers will host a meeting and discuss the existing evidence on the topic on the same day.
When asked whether the similar names, meeting dates, and purported goals could sow confusion in the autism community about who to trust, she responded, “Are you going to pay attention to the group that contains not a single reputable scientist, or anyone experienced with conducting research? Or are you going to look at a group of people, which includes the people who have all the credentials that you would expect from the membership of the IACC?”
The Department of Health and Human Services has no plans to change the federal body’s proceedings in response to their independent counterpart. “The federal IACC will continue to fulfill President Trump’s directive to bring autism research to the 21st century and support breakthroughs in autism diagnosis, treatment, and prevention,” said Andrew Nixon, an HHS spokesperson.
This is not the first group of researchers and advocates who have formed their own advisory group as a bid to push back against misinformation from the federal government. The Vaccine Integrity Project launched last year as a means for assessing and disseminating the best available evidence on vaccines.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























